Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizoribine vs Mycophenolate Mofetil in Living Related Kidney Transplantation
NCT06114953Phase 4Recruiting
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jan 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mizoribine in kidney transplant rejection, sponsored by Lee's Pharmaceutical Holdings Limited. Started Jan 2023; status: recruiting.
02
Drugs
mizoribine
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT06114953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06114953.